SCHEMBL26416703

SCHEMBL26416703

c1ccc(-c2nc(-c3ccc(-c4cccc5oc6cc(N(c7ccccc7)c7ccccc7)ccc6c45)cc3)nc(-c3ccc4ccccc4c3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
KDM4E B2RXH2 5/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
TP53 P04637 2/20 0.37
HSD17B10 Q99714 2/20 0.37
CYP1A2 P05177 2/20 0.37
MAPT P10636 5/20 0.33
NR1H4 Q96RI1 1/20 0.33
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
MAPK1 P28482 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ATM Q13315 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HSD17B1 P14061 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26778825 0.96 ALDH1A1 (0.34) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL25848751 0.95 ALDH1A1 (0.36) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL26778828 0.94 ALDH1A1 (0.35) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL26778852 0.94 ALDH1A1 (0.34) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL26416682 0.93 MAPT (0.33) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL25978292 0.93 ALDH1A1 (0.34) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL26415613 0.92 ALDH1A1 (0.34) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL24255611 0.92 ALDH1A1 (0.34) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL26415727 0.92 ALDH1A1 (0.36) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL26415594 0.91 ALDH1A1 (0.34) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 ALDH1A1 27/4885KDM4E 3080/4885SMN1; SMN2 4152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.